Advancing Clinical Research by Combining Machine Precision and Human Intuition
Mendel.ai has raised $40.0M in total funding. The most recent round was Series B. The last funding was announced in March 2022.
Mendel.ai's investors include Oak HC/FT, Olive Tree Capital, SOSV, DCM Ventures, SOSV SF & NY (Fka IndieBio).
Mendel.ai is headquartered in San Jose, United States.
Advancing Clinical Research by Combining Machine Precision and Human Intuition
Mendel.ai is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mendel.ai — Funding & Investors." VCBacked, March 25, 2022, https://www.vcbacked.co/company/mendelai. Accessed August 13, 2026.
VCBacked. (2022). Mendel.ai — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/mendelai
{{cite web |title=Mendel.ai — Funding & Investors |url=https://www.vcbacked.co/company/mendelai |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated